2.3. Design and Procedure
The study used a double-blind, placebo-controlled, cross-over design and was conducted between September 2019 and September 2020. Part of the results and the sample of this study were reported elsewhere [After taking blood samples in a fasting state (t = −10 and −1 min), subjects received one of the solutions (at t = 0 min) via the nasogastric feeding tube over two minutes.More blood samples were taken at t = 15, 30, 45, 60, 90, 120 and 180 min for the analysis of glucose, insulin and ghrelin, and at t = 30, 60, and 120 min, for analysis of blood lipids, uric acid and hsCRP (